ES477216A1 - Un procedimiento para la produccion de un nuevo derivado de prostaglandina. - Google Patents

Un procedimiento para la produccion de un nuevo derivado de prostaglandina.

Info

Publication number
ES477216A1
ES477216A1 ES477216A ES477216A ES477216A1 ES 477216 A1 ES477216 A1 ES 477216A1 ES 477216 A ES477216 A ES 477216A ES 477216 A ES477216 A ES 477216A ES 477216 A1 ES477216 A1 ES 477216A1
Authority
ES
Spain
Prior art keywords
prostaglandine
derivatives
prostaglandine derivatives
effect
prostaglandines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES477216A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53009652A external-priority patent/JPS5850236B2/ja
Priority claimed from JP10443478A external-priority patent/JPS5845440B2/ja
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of ES477216A1 publication Critical patent/ES477216A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Los derivados de prostaglandina están constituido por una prostaglandina y una hormona esteroide, con o sin un grupo enlazante. Los derivados de prostaglandina presentan efectos secundarios extraordinariamente reducidos y una actividad fisiológica superior, especialmente un efecto de aborto, en comparación con los de las prostaglandinas.
ES477216A 1978-01-31 1979-01-26 Un procedimiento para la produccion de un nuevo derivado de prostaglandina. Expired ES477216A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53009652A JPS5850236B2 (ja) 1978-01-31 1978-01-31 プロスタグランジン類↓−ステロイドホルモン結合体
JP10443478A JPS5845440B2 (ja) 1978-08-29 1978-08-29 プロスタグランジン誘導体とその製造方法及び薬剤

Publications (1)

Publication Number Publication Date
ES477216A1 true ES477216A1 (es) 1980-03-01

Family

ID=26344419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES477216A Expired ES477216A1 (es) 1978-01-31 1979-01-26 Un procedimiento para la produccion de un nuevo derivado de prostaglandina.

Country Status (16)

Country Link
US (1) US4198405A (es)
AR (1) AR223473A1 (es)
AU (1) AU519132B2 (es)
CA (1) CA1125742A (es)
CH (1) CH639668A5 (es)
DE (1) DE2900061C2 (es)
DK (1) DK159455C (es)
ES (1) ES477216A1 (es)
FI (1) FI68811C (es)
FR (1) FR2422686A1 (es)
GB (1) GB2015528B (es)
IL (1) IL56430A (es)
IT (1) IT1110751B (es)
NL (1) NL187485C (es)
NO (1) NO151087C (es)
SE (5) SE441006B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318908A (en) * 1979-12-06 1982-03-09 Kureha Kagaku Kogyo Kabushiki Kaisha Methylated prostaglandin derivatives
US4784960A (en) * 1981-09-24 1988-11-15 Peter S. Brune Process for preparation of control for use in progesterone receptor
US4423151A (en) * 1981-09-24 1983-12-27 Peter S. Brune Process for preparation of control for use in estrogen receptor tests
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
CN1906206A (zh) * 2004-01-15 2007-01-31 沃纳奇尔科特公司 雌二醇的二－甾族前体药物
MXPA06007851A (es) * 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de etinil estradiol.
WO2007024338A2 (en) * 2005-07-12 2007-03-01 Warner Chilcott Company, Inc. 3 -ester prodrugs of ethynylestradiol
US20070015741A1 (en) * 2005-07-12 2007-01-18 James Keown Novel prodrugs of estradiol
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839409A (en) * 1958-05-28 1974-10-01 Kemiska Inst Karolinska I Pge3 esters and alkanoates
US3732261A (en) * 1971-12-03 1973-05-08 Nelson Res & Dev Steroid compounds
JPS5829318B2 (ja) * 1974-03-11 1983-06-22 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ホウホウ

Also Published As

Publication number Publication date
FI790281A (fi) 1979-08-01
SE8305322D0 (sv) 1983-09-29
SE441006B (sv) 1985-09-02
SE8305324D0 (sv) 1983-09-29
DK6179A (da) 1979-08-01
CH639668A5 (de) 1983-11-30
FI68811B (fi) 1985-07-31
SE448870B (sv) 1987-03-23
SE8305321D0 (sv) 1983-09-29
SE8305322L (sv) 1983-09-29
DK159455C (da) 1991-03-18
NO790297L (no) 1979-08-01
AR223473A1 (es) 1981-08-31
NL7900071A (nl) 1979-08-02
GB2015528B (en) 1982-10-27
SE8305321L (sv) 1983-09-29
GB2015528A (en) 1979-09-12
SE8305323D0 (sv) 1983-09-29
SE448873B (sv) 1987-03-23
CA1125742A (en) 1982-06-15
NO151087C (no) 1985-02-06
US4198405A (en) 1980-04-15
IL56430A0 (en) 1979-03-12
SE8305324L (sv) 1983-09-29
SE7900086L (sv) 1979-08-01
SE8305323L (sv) 1983-09-29
AU4254578A (en) 1979-08-09
NL187485C (nl) 1991-10-16
IT1110751B (it) 1986-01-06
NL187485B (nl) 1991-05-16
NO151087B (no) 1984-10-29
DK159455B (da) 1990-10-15
FR2422686B1 (es) 1982-11-19
IL56430A (en) 1984-03-30
DE2900061C2 (de) 1982-04-01
DE2900061A1 (de) 1979-08-02
IT7919091A0 (it) 1979-01-05
SE448871B (sv) 1987-03-23
FR2422686A1 (fr) 1979-11-09
SE448872B (sv) 1987-03-23
AU519132B2 (en) 1981-11-12
FI68811C (fi) 1985-11-11

Similar Documents

Publication Publication Date Title
US4109960B1 (en) Legless rocker-recliner chair
ES477216A1 (es) Un procedimiento para la produccion de un nuevo derivado de prostaglandina.
IL61037A (en) Demorphins,a new class of peptides with opiate-like activity and pharmaceutical compositions comprising them
NL300144I2 (nl) 20-Spiroxanen en analoga met geopende ring E, werkwijzen ter bereiding ervan, alsmede farmaceutsche preparaten ervan.
GB1557645A (en) Enzyme preparations
AU507697B2 (en) Noble-metal-containing catalyst, its preparation and use
JPS5359568A (en) Knockdown chair
JPS5350364A (en) Enzyme preparations
JPS5289700A (en) Medical composition having antiiulcer activity
GB2048918B (en) Physiologically active polysaccharide
OA07332A (fr) Oximes-éthers, leur préparation et leur utilisation.
JPS52146991A (en) Therapeutic chair
AU2241077A (en) Heart valve prosthesis
DE2960621D1 (en) Hydroxypropyl imidazoles, their preparation and medicaments containing them
SE7412058L (es)
ES424853A1 (es) Un procedimiento para obtener compuestos utiles en agricul-tura.
GB2038625B (en) Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
AU508349B2 (en) Novel g-acetamidophenol derivatives, their preparation and their use as therapeutic agents
ES480153A1 (es) Procedimiento para preparar 3-n-acil-n-arilamino-gamma-buti-rolactonas y butirotiolactonas.
IT8421820A0 (it) Preparazione del 3,3,3-trifluoro-2-trifluorometilpro pene.
NZ183842A (en) Immunological oral medicament for treatment and preventionof gastroenteritis, partucularly infantile gastroenteritis
JPS5369833A (en) Drug having strengthened activity
IT8721657A0 (it) Eteri e tioeteri ad attivita'terapeutica, loro preparazione e composizioni che li contengono.
ZA784754B (en) Biologically active hydrazones
Marx A Tribute to Abraham Lincoln